9 Things to Know Before Taking Ashwagandha When You Have Thyroid Disease and Are in Perimenopause
A lot of women in this community have thyroid conditions and perimenopause happening at the same time — and the symptom overlap is genuinely maddening. When ashwagandha gets recommended for the exhaustion and the anxiety, it sounds like a clean win. But finding out later that it nudged thyroid levels enough to need a medication adjustment, or tipped someone into palpitations, is the kind of thing that deserves a proper warning upfront, not a footnote.
Learn more about Rose →Ashwagandha can measurably raise T3 and T4 levels
Clinical studies have shown that ashwagandha root extract increases serum triiodothyronine (T3) and thyroxine (T4) concentrations, likely by stimulating thyroid hormone synthesis or enhancing sensitivity of thyroid tissue. For someone with an underactive thyroid, this might sound like a bonus — but it means the herb is actively altering hormone output, not simply supporting general wellbeing. For anyone on levothyroxine or other thyroid medication, this shift can push levels outside the therapeutic range without any change in prescription.
The interaction is especially unpredictable when estrogen is fluctuating
Estrogen directly affects thyroid-binding globulin (TBG), the protein that transports thyroid hormones in the blood — when estrogen rises, TBG rises, and more thyroid hormone gets bound and becomes inactive. During perimenopause, estrogen levels are erratic rather than simply declining, meaning TBG and free thyroid hormone levels are already moving targets. Adding ashwagandha's thyroid-stimulating effect into that fluctuating system makes it genuinely difficult to predict how thyroid labs will look from one month to the next.
Women with Hashimoto's face a specific autoimmune consideration
Hashimoto's thyroiditis is an autoimmune condition, and ashwagandha has immunomodulatory properties — it can influence immune activity, which in theory could affect the autoimmune process driving thyroid damage. The evidence here is not definitive in either direction, but some integrative practitioners report that immune-stimulating supplements can provoke flares in autoimmune thyroid disease in certain individuals. Women with Hashimoto's who are already managing antibody levels alongside perimenopause symptoms deserve a more cautious, monitored approach rather than a casual start.
Hyperthyroidism and Graves' disease are contraindications worth taking seriously
For women with an overactive thyroid or Graves' disease, an herb that further elevates thyroid hormone output is a genuine risk — potential consequences include worsening palpitations, anxiety, heat intolerance, and in serious cases, thyrotoxic episodes. This is particularly relevant in perimenopause because symptoms like heart racing, sweating, and anxiety are already common and can mask signs that thyroid levels are climbing. Ashwagandha is not appropriate for women with untreated or unstable hyperthyroidism, and even those who are well-controlled should only consider it with physician oversight.
Symptom overlap makes it hard to notice when something is off
Perimenopause and thyroid dysfunction share a remarkable number of symptoms — fatigue, brain fog, mood changes, weight shifts, sleep disruption, and temperature sensitivity — which means a woman experiencing these may not notice if ashwagandha is tipping her thyroid out of range until the change is significant. Standard advice to 'listen to your body' falls short here because the body is already sending confusing, overlapping signals. Baseline thyroid labs before starting and a recheck at six to eight weeks is a more reliable approach than symptom monitoring alone.
Ashwagandha also lowers cortisol — which has its own thyroid-related consequences
One of ashwagandha's most reliable and well-studied effects is reducing cortisol, the primary stress hormone produced by the adrenal glands. Cortisol and thyroid hormones are metabolically linked — chronically elevated cortisol suppresses thyroid function, but a rapid drop in cortisol can also shift the thyroid axis in ways that are not always straightforward. For women in perimenopause whose HPA axis (the stress-hormone system) is already being disrupted by fluctuating estrogen and progesterone, this cortisol-lowering effect adds another variable to an already complex picture.
The dose and form matter significantly, and supplements are not standardised
The studies showing thyroid hormone elevation used specific standardised root extracts at defined doses — typically 300mg to 600mg of a root extract standardised to withanolide content. The ashwagandha products widely available vary enormously in potency, plant part used, and actual withanolide concentration, meaning the hormonal effect of a 'daily wellness gummy' is not comparable to what was studied. Women with thyroid conditions should be especially cautious about products with vague dosing, as the thyroid-stimulating effect is likely dose-dependent.
It can interact with thyroid medications by altering how they work
Beyond its direct effect on thyroid hormone production, ashwagandha may influence the absorption or metabolism of thyroid medications, though the research on this specific interaction is limited. Because levothyroxine has a narrow therapeutic window — meaning the difference between too little and too much is small — even modest changes in absorption or thyroid hormone output can shift a woman outside her optimal range. Any woman taking thyroid medication should flag ashwagandha as clearly as she would flag another prescription drug when speaking with her prescribing doctor.
There are evidence-based alternatives for the perimenopause symptoms ashwagandha is typically targeting
Ashwagandha is most often recommended in perimenopause for stress resilience, fatigue, and sleep — and for women with thyroid disease who cannot use it safely, there are other approaches with reasonable evidence that do not carry the same thyroid-interacting risk. Magnesium glycinate has solid evidence for sleep and anxiety without thyroid effects; phosphatidylserine has been studied for cortisol modulation; and for some women, addressing thyroid optimisation itself (ensuring TSH is in the lower half of normal range) dramatically improves the fatigue and brain fog driving them toward adaptogens in the first place. It is worth exploring whether the thyroid is fully optimised before adding supplements on top of an undertreated condition.
Want to go deeper?
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.